Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Researchers identify key gene necessary for cells to consume and destroy viruses

A team led by UT Southwestern researchers has identified a key gene necessary for cells to consume and destroy viruses. The findings, reported online today in Nature, could lead to ways to manipulate this process to improve the immune system's ability to combat viral infections, such as those fueling the ongoing COVID-19 pandemic.

17 Dec 2020

Specific genetic target could help explain the variation in COVID-19 effects

The Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has identified a specific genetic target that could help explain the tremendous variation in how sick those infected with COVID-19 become.

17 Dec 2020

Researchers use bacterial strains to measure host gene expression in mouse model

The bacteria Streptococcus pneumoniae colonizes the nasopharynx and can cause pneumonia. Then, it can spread from the lungs to the bloodstream and cause organ damage.

16 Dec 2020

Ignoring CDC recommendations enhances fear and anger among employees

Companies worldwide are facing unprecedented challenges due to the COVID-19 pandemic, from modifying operations to keeping employees safe and informed. But not all businesses have followed the recommended safety protocols set by the Centers for Disease Control and Prevention.

16 Dec 2020

Research reveals two phases of infection in patients with severe COVID-19 pneumonia

What does SARS-CoV-2, the virus that causes COVID-19, do once it enters a person's airways, and how does infection in lung cells affect patients' immune responses?

16 Dec 2020

Researchers focus on preventing infections caused by carbapenemase-producing bacteria

In 2017, the World Health Organization published a list of pathogens for which new drugs are urgently needed.

16 Dec 2020

LRA survey: Two-thirds of people with lupus are willing to take COVID-19 vaccine

Two out of three people with lupus (64%) are willing to take a COVID-19 vaccine if it is free and determined safe by scientists according to results of a survey conducted by the Lupus Research Alliance.

16 Dec 2020

Traditional herbal medicine Respiratory Detox Shot (RDS) inhibits SARS-CoV, SARS-CoV-2 and Influenza A infection in vitro

As researchers continue to search for antivirals to counter COVID-19, a study presents the potential utility of a decoction called Respiratory Detox Shot (RDS).

16 Dec 2020

Azithromycin trial fails to provide evidence of benefit in COVID-19

Early on in the COVID-19 pandemic, azithromycin was regarded as being a potentially highly effective drug against the virus that causes it, SARS-CoV-2.

16 Dec 2020

Chemical found in cigarettes could increase severity of COVID-19, new study finds

A new study has found that high levels of the chemical cadmium, is associated with an increased risk of death in patients with influenza or pneumonia.

16 Dec 2020

Survey suggests COVID-19 vaccine hesitancy stems from a distrust in the vaccine development and approval process

Survey results of COVID-19 vaccine hesitancy suggest that people are less likely to get the COVID-19 vaccine than the number of people who got the flu shot.

16 Dec 2020

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

A new study reveals that the genome of SARS-CoV-2 is inserted into the human genome, accounting for the detection of viral RNAs.

16 Dec 2020

BAT advances COVID-19 vaccine candidate into phase-I clinical trial

The COVID-19 vaccine candidate (KBP-COVID-19; NCT04473690) will become one of a number of potential vaccines to have progressed beyond pre-clinical testing.

16 Dec 2020

Using hypoxia adaptations in marine mammals to understand COVID-19

News-Medical talks to Terrie Williams about how the diving physiology that adapts marine mammals to hypoxia can improve our understanding of COVID-19.

16 Dec 2020

RedHill Biopharma announces promising preliminary results from opaganib study

TEL AVIV, Israel and RALEIGH, NC, December 15, 2020, RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced promising preliminary results from a preclinical study with opaganib.

15 Dec 2020

Study shows COVID-19 infection does not damage the auditory system

Since the beginning of the COVID-19 pandemic, there have been reports in the professional literature on possible hearing loss caused by the disease. A new study from Tel Aviv University (TAU), in collaboration with the Galilee Medical Center, finds no evidence of damage to the auditory system as a result of COVID-19 infection.

15 Dec 2020

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Researchers identify key gene necessary for cells to consume and destroy viruses

Specific genetic target could help explain the variation in COVID-19 effects

Researchers use bacterial strains to measure host gene expression in mouse model

Ignoring CDC recommendations enhances fear and anger among employees

Research reveals two phases of infection in patients with severe COVID-19 pneumonia

Researchers focus on preventing infections caused by carbapenemase-producing bacteria

LRA survey: Two-thirds of people with lupus are willing to take COVID-19 vaccine

Traditional herbal medicine Respiratory Detox Shot (RDS) inhibits SARS-CoV, SARS-CoV-2 and Influenza A infection in vitro

Azithromycin trial fails to provide evidence of benefit in COVID-19

Chemical found in cigarettes could increase severity of COVID-19, new study finds

Survey suggests COVID-19 vaccine hesitancy stems from a distrust in the vaccine development and approval process

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

BAT advances COVID-19 vaccine candidate into phase-I clinical trial

Using hypoxia adaptations in marine mammals to understand COVID-19

RedHill Biopharma announces promising preliminary results from opaganib study

Study shows COVID-19 infection does not damage the auditory system

Study: COVID-19 patients have greater risk of health problems, mortality than those with flu

Drug may increase vaccine protection in older adults

Flavobac™ Cold & Flu Guard provides a natural barrier against bacteria and viruses

Pediatricians want kids to be part of COVID vaccine trials

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in